Current Relevance of Hepatic Arterial Therapy (HAT) in the Era of Routine Molecular Targeted Therapy for Treatment of Hepatic Malignancy-A Practice Based Approach

HAT has survived it's comparators as it has successfully evolved from hepatic artery chemotherapy(HAC), bland embolization (HAE), chemo-embolization (HACE) to;chemo bead embolization(HACBE), radioactive bead embolization(HARBE). The HAC is only indicated routinely in selected post hepatic metastatectomy patients with colorectal cancer whereas HACE and HARBE are routine choice for selected unresectable HCC.